Target intelligence / Profile preview

Escherichia coli F1Fo-ATP synthase (E. coli ATP synthase)

Target
E. coli ATP synthase
Molecular classification
Enzyme, Transporter, F-type ATPase, Rotary motor protein
01

Overview

Escherichia coli F1Fo-ATP synthase is a complex, membrane-bound enzyme that plays a central role in energy transduction by coupling the flow of protons across the inner membrane to the synthesis of adenosine triphosphate (ATP) (UniProt Consortium, 2023). The enzyme is composed of two distinct sectors: the F1 catalytic domain, which extends into the cytoplasm, and the Fo proton-conducting domain, which is embedded within the phospholipid bilayer (Walker, 2013). In E. coli, the enzyme is reversible, allowing it to either produce ATP during oxidative phosphorylation or maintain a proton gradient through ATP hydrolysis during fermentation (Ahmad et al., 2020). Because of its vital role in maintaining cellular energy homeostasis and the proton motive force, it is a prominent target for antimicrobial research (Hong-Geller et al., 2020). While many clinical inhibitors like bedaquiline are specific to mycobacteria, the E. coli enzyme serves as the primary structural and functional model for understanding bacterial F-type ATPases. Therapeutic strategies targeting this enzyme aim to disrupt bacterial viability by depleting energy reserves or collapsing the electrochemical gradient. However, a major challenge in drug development is ensuring selectivity to avoid inhibiting the highly conserved human mitochondrial ATP synthase (PubMed, 2021).

Other names
F-type ATPaseF1Fo-ATPaseH(+)-transporting two-sector ATPaseATP phosphohydrolaseBacterial ATP synthase
02

Mechanism of action

Inhibition of the rotary catalysis mechanism by either blocking the Fo proton channel or binding to the F1 catalytic subunits, thereby preventing the coupling of proton translocation to ATP synthesis/hydrolysis.

03

Biological functions

ATP synthesisProton transmembrane transportEnergy metabolismpH regulationMaintenance of proton motive force
04

Disease associations

InfectionBacterial infection
05

Safety considerations

Potential cross-reactivity with human mitochondrial ATP synthase (Complex V) due to structural conservationDisruption of beneficial host microbiotaDevelopment of antimicrobial resistance through target site mutations
06

Interacting drugs

N,N'-Dicyclohexylcarbodiimide (DCCD)

5 more in the full profile.

07

Biomarkers

Intracellular ATP levelsCytoplasmic pHProton motive force (PMF) magnitudeBacterial growth rate

Beyond the preview

Go deeper on Escherichia coli F1Fo-ATP synthase (E. coli ATP synthase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli F1Fo-ATP synthase (E. coli ATP synthase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call